Merad Pharmaceuticals Limited - Limited company - abbreviated - 11.9

REGISTERED NUMBER: 04024112 (England and Wales)

Abbreviated Unaudited Accounts for the Year Ended 30 June 2015

for

Merad Pharmaceuticals Limited

Page

Abbreviated Balance Sheet

1

Notes to the Abbreviated Accounts

3

FIXED ASSETS

Tangible assets

2

55,377

56,460

CURRENT ASSETS

Debtors

29,334

58,785

Cash at bank

5,245

2,511

34,579

61,296

CREDITORS

Amounts falling due within one year

54,383

34,926

NET CURRENT (LIABILITIES)/ASSETS

(19,804

)

26,370

TOTAL ASSETS LESS CURRENT LIABILITIES

35,573

82,830

CAPITAL AND RESERVES

Called up share capital

3

100

100

Profit and loss account

35,473

82,730

SHAREHOLDERS' FUNDS

35,573

82,830

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 17 March 2016 and were signed on its behalf by:

Mrs N Kumar - Director

Dr R Kumar - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

2% on cost

Plant and machinery

-

25% - 50% on reducing balance

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

2.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 July 2014

94,845

Additions

848

At 30 June 2015

95,693

DEPRECIATION

At 1 July 2014

38,385

Charge for year

1,931

At 30 June 2015

40,316

NET BOOK VALUE

At 30 June 2015

55,377

At 30 June 2014

56,460

3.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2015

2014

value:

£

£

100

Ordinary

£1

100

100

4.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the year end and included within other creditors is an amount due to the directors, Mrs N Kumar and Dr R

Kumar, amounting to £224 ( 2014 £5,367 ).

This loan is interest free and repayable on demand.